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A B S T R A C T
Introduction: Chronic pain and the pattern of opioid use after skeletal fractures has been a neglected topic
in pain medicine. Pelvic and in particular acetabular fractures represent some of the most troublesome
injuries for patients with a high incidence of chronic pain after fracture. We examined the long-term
opioid analgesic use among patients with acetabular fractures and analysed if potential risk factors
would predict a prolonged opioid therapy.
Patients and methods: Data were extracted from medical databases such as the Swedish National
Hospital Discharge Register and the National Pharmacy Register. The study period was 2005–2008.
Kaplan–Meier analysis constructed the cumulative opioid consumption with 95% conﬁdence intervals
(CI). Cox multiple-regression model was used to study risk factors for a prolonged opioid prescription
after admission for fracture. An age- and sex-matched control group was included for comparisons.
Results: We identiﬁed 1017 patients with isolated acetabular fractures. The proportion of dispensing
opioids for these patients was 39%, which was 7 times higher than in the age- and sex-matched non-
fracture controls (n = 5077). The median follow-up time was 14 (interquartile range [IQR] 5–24) months.
Most patients with opioid use after fracture were male (60%) and the median age was 76 (IQR 61–85)
years. The leading mechanism of injury was fall on the same level (52%). At 6 and 12 months after
fracture, 41% (95% CI 36–47) and 33% (28–39) were still treated with opioids. The multiple Cox
regression-analysis (adjusted for age, sex, type of treatment, and mechanism of injury) revealed that
younger patients (age <70 compared with 70 years) were more likely to end using opioids (Hazard
ratio 2.0 [95% CI 1.5–2.7]). The median daily morphine equivalent dose was 22 (IQR 14–42) mg within
the ﬁrst month after fracture.
Discussion: During follow-up, the frequency of patients on moderate and high doses was falling off.
There was no evidence of analgesic tolerance in the majority of the patients who were treated for at least
6 months. To set our ﬁndings into perspective, studies of patterns of chronic opioid use among patients
with other types of fractures would be valuable.
 2012 Elsevier Ltd. 
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The awareness of chronic pain as an important patient concern
has increased the prescription of strong opioid analgesic drugs to
non-malignant pain conditions over time.3 Eriksen et al. reported
that in the Danish population, approximately 3% of the adult
population and 12% of patients with chronic pain regularly use
opioids for the therapy of long-lasting non-cancer pain.6 The* Corresponding author at: Department of Molecular Medicine and Surgery,
Section of Orthopaedics and Sports Medicine, Karolinska University Hospital/
Karolinska Institutet, S-171 76 Stockholm, Sweden. Tel.: +46 08 51770000;
fax: +46 08 51772695.
E-mail address: rudiger.weiss@karolinska.se (R.J. Weiss).
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Open access under the Elsevier OA license.acceptance for the potential long-term beneﬁts of opioids in the
spectrum of chronic pain management is increasing, however,
there is still substantial concern with regard to abuse, addiction,
adverse effects, and the potential problem of dose escalation due to
development of analgesic tolerance.22,24
Pelvic and in particular acetabular fractures are a rare entity in
the ﬁeld of skeletal injuries after trauma. Still, they represent some
of the most troublesome fractures for patients and surgeons.12 The
golden standard for displaced acetabular fractures is surgery, yet
the operative ﬁxation remains a major challenge with a high
complication rate and poor functional outcome in a signiﬁcant
amount of patients.11,16,17
Chronic pain and the pattern of opioid use after skeletal
fractures and surgery has been a neglected topic in pain
medicine.13 Previous studies have shown that chronic pain after
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Therefore, we examined the long-term opioid analgesic use among
patients with acetabular fractures. Using data from the National
Pharmacy Register we determined the prevalence of long term
opioid consumption and the development of tolerance as indicated
by increased doses over time. In addition, we analysed if potential
risk factors such as age, sex, type of treatment, and mechanism of
injury would predict a prolonged opioid therapy.
2. Patients and methods
2.1. Source of data
The Swedish National Hospital Discharge Register (SNHDR)
provided data on patients with acetabular fractures. The Register
collects information on all inpatient care in Sweden including
diagnoses according to the International Classiﬁcation of Diseases
(ICD). As controls, an age- and sex-matched cohort without
acetabular fractures was extracted from the Total Population
Register. Data on death and emigration for both cohorts were
retrieved from Statistics Sweden.
All prescriptions dispensed at pharmacies, with the exception of
over-the-counter sales and drugs given to patients during
hospitalisation, are stored in the National Pharmacy Register
since July 1, 2005.1 Over-the-counter sales include some pain
medicine such as paracetamol and nonsteroidal antiinﬂammatory
drugs, however opioid analgesics are available by prescription
only. Data linkage between the different registers used the
personal identiﬁcation number issued to all Swedish residents.
2.2. Study design
We extracted data from all individuals registered in the SNHDR
with ICD-10 codes of acetabular fractures (S324, S3240, and
S3241). Relevant surgical intervention codes for open reduction
and internal ﬁxation (NEJ69–99) and total hip joint arthroplasty
(NFB29–49) were analysed accordingly. Mechanisms of injury
were studied according to ICD E-codes (external codes) and
grouped in 6 categories: fall on the same level, fall from height, fall
unspeciﬁed, transport accident, miscellaneous, and not reported.
The study period was July 1, 2005 to December 31, 2008. Each
patient in the fracture cohort was matched with 5 individuals by
age, sex, and residential area. The control group was extracted from
the Total Population Register. None of the controls from the
matched cohort did have a fracture of the acetabulum during the
observation period.
All opioid analgesics prescribed to the study population and the
matched cohort were gathered from the National Pharmacy
Register. These data contain the drug name, the day of dispensing,
the prescribed amount, and the dosage. The morphine equivalent
dose (MED) in milligram (mg) for each opioid was calculated by
multiplying the number of pills prescribed by the drug strength.
These doses were then converted to the MED using available
equianalgesic conversions.23 The median daily MED dispensed was
then calculated for each month. Moreover, the opioid therapy was
divided in the following categories: low dose, 20 mg MED per
day; moderate, 20  180 mg; and high, >180 mg.3,2 The distribu-
tion of patients in the respective categories was calculated for
different exposure windows after the fracture: 1, 1–2, 3–6, 7–12,
and 13–24 months. Opioids have previously been classiﬁed as
weak (propoxyphene, codeine, tramadol) and strong (oxycodone,
morphine, fentanyl).9 Our analysis does not include weak but only
strong opioids. We excluded all patients with fractures other than
the acetabular fracture at the index hospitalisation or during
follow-up, as we did not want to be biased by associated fractures.The regional ethical review board located at the Karolinska
Institutet approved the study (2009/837-31/3 and 2010/0125-32).
2.3. Statistical analysis
Median values with interquartile ranges (IQR) were used as
descriptive statistics. Kaplan–Meier analysis constructed the
cumulative opioid consumption with 95% conﬁdence intervals
(CI). An event was deﬁned as the last opioid prescription. Cessation
of opioid therapy was deﬁned as having no new prescription for at
least three consecutive months. Three months were chosen as this
is the maximum time interval for prescribing opioid analgesics.
We used the Cox multiple-regression model to study risk
factors for a prolonged opioid prescription after admission for
fracture. The results of the Cox-regression analysis were expressed
as hazard ratios (HR) with corresponding 95% CI. If the HR is >1, the
patients are more likely to end dispensing opioids compared with
patients in the reference group. Risk factors studied in the simple
Cox model were age, sex, type of treatment (surgical versus non-
surgical), and mechanism of injury. All variables were later
adjusted for in a multiple Cox model.
Logistic regression analysis compared the group of patients
receiving opioid analgesics after the fracture with those who never
had any opioid prescription during follow-up. The dependent
variable in the model was opioid use (yes/no) and covariates were
age, sex, type of treatment, and mechanism of injury. The level of
signiﬁcance was set at p  0.05. All statistical analyses were
performed using the PASW statistics package version 18 (SPSS Inc.,
Chicago, IL, USA).
3. Results
3.1. Study participants
We could identify 2127 individual patients with acetabular
fractures in the SNHDR. An isolated acetabular fracture without
associated fractures was found in 1138 (54%) patients. Some 989
(46%) patients with combinations of acetabular fracture and other
fractures were excluded. The crude opioid use among patients with
isolated acetabular fracture was 45% (n = 517). We excluded 121
(11%) patients who received morphine prescriptions prior to the
index hospitalisation, as we wanted to study new opioid use after
fracture. This left us with a ﬁnal sample size of 1017 patients. Of
those, had 396 (39%) patients opioid prescriptions after the
acetabular fracture (new opioid use). The corresponding age- and
sex-matched control group consisted of 5077 individuals. Pre-
scriptions of opioid analgesics was seen in 295 (6%) controls during
the same follow-up period.
The majority of the patients with new opioid use after
acetabular fracture were male (n = 237, 60%). The median age
was 76 (IQR 61–85) years and a large proportion of the participants
was over 80 years old (n = 171, 43%). The mechanism of injury
leading to the acetabular fracture was dominated by falls on the
same level (n = 204, 52%), followed by unspeciﬁed falls (n = 75,
19%), transport accidents (n = 47, 12%), fall from height (n = 35, 9%),
miscellaneous (n = 25, 6%), and not reported (n = 10, 2%). Most
patients with new opioid use were treated non-surgically (n = 305,
77%). The median follow-up time after fracture was 14 (IQR 5–24)
months.
3.2. Opioid prescriptions
At 6, 12, and 18 months after the acetabular fracture 100 (41%,
95% CI 36–47), 60 (33%, 28–39), and 36 (28%, 22–34) patients still
required opioid prescriptions, respectively (Fig. 1). For those
patients, who started on opioid analgesics, the median daily MED
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Fig. 1. Kaplan–Meier-analysis with 95% conﬁdence intervals of the last opioid
prescription of patients with acetabular fractures.
Fig. 3. The distribution of opioid prescriptions in 396 patients in different time
intervals after acetabular fracture (low dose, 20 mg MED per day; moderate,
20  180 mg; high >180 mg; MED = morphine equivalent dose).
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and 21 (IQR 13–42) mg within the second month (Fig. 2).
Comparison of the daily MED among individuals who both had
prescriptions for continuing treatment from the ﬁrst to the sixth
month indicated that the majority of these patients (72%, 21/29)
did not have dose escalations (an increase by more than 30% of the
original dose).
Fig. 3 shows the distribution of patients on various doses during
different exposure windows. Most patients ﬁlled the ﬁrst opioid
prescription within the ﬁrst month after the fracture (76%). During
follow-up, the proportion of patients who stopped with opioid
drugs was increasing, whilst the frequency of patients on moderate
and high doses was falling off (Fig. 3).
The simple Cox regression-analysis revealed that demographic
age under 70 years (HR 2.1), surgery (HR 1.3), fall from height (HR
1.6), and transport accident (HR 2.0) as the mechanism of injury
made it less likely to continue opioid analgesic use. After
adjustment for all covariates in the multiple Cox model, only1 2 3 4 5 6 7 8 9 10 11 12
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Fig. 2. The median (interquartile range) morphine equivalent dose (MED) in
milligram (mg) per day prescribed to patients with acetabular fractures in different
time periods after fracture (n = number of patients).younger age remained as a statistically signiﬁcant predictor for
ending opioid use (HR 2.0) (Table 1).
We compared the patients with isolated acetabular fractures
and new opioid use (n = 396) with those who did not obtain opioids
at all (n = 621). There was no difference concerning age, sex, and
mechanism of injury between the two groups (data not shown).
However, patients receiving opioid analgesics during follow-up
were more likely to have undergone surgery (odds ratio 2.3, 95% CI
1.6–3.3, p < 0.001).
4. Discussion
The use of opioids for pain management in patients with
chronic non-cancer pain has continuously increased during the
past decades. We studied the long-term opioid prescriptions after
fractures of the acetabulum on a nationwide basis in Sweden.
Nearly 40% of the patients dispensed opioid analgesics after
fracture. The opioid use was 7 times higher than in the age- and
sex-matched non-fracture controls. A third of patients still
received prescriptions for opioid analgesic drugs one year after
the fracture. However, the doses used were rather low and we
could not detect any major increased development of tolerance
over time, as signalled by increases in dose. We can only assume
that pain was the reason for opioid use, since the registers used for
this study do not include data on the prevalence of chronic pain.
However, using opioid prescription as a proxy for chronic pain may
be appropriate.
In a 10 year follow-up study on the outcome of 161 surgically
treated patients with acetabular fractures, Briffa et al. reported that
complications were common both in the medium- and long-term.
The results were variable with a signiﬁcant amount of patients
having either fair or poor outcome (27%).4 Pohlemann et al.
documented the prevalence of chronic posttraumatic pelvic pain in
83% of the cases with isolated acetabular fractures after 2 years of
follow-up.21 Meyhoff et al. found a high incidence of chronic pain
after surgery for pelvic fractures (48%) and acetabular fractures (22
of 45 patients) at a median follow-up of 6 years. The use of opioid
analgesics was common among these patients (14%).18 Other
authors conﬁrm the high incidence of chronic pain after acetabular
fracture.10 These ﬁndings may partly explain the extended use and
prescription of opioids several months after fracture.
In accordance to previous reports, we found a male predomi-
nance.10,18,4,7 Our ﬁnal study sample that was started on a new
opioid treatment is characterized by a high median age and a low
proportion of transport accidents. Ferguson et al. showed that the
incidence of acetabular fractures in elderly patients is increasing.7
Table 1
396 patients with new opioid use after acetabular fracture (Cox regression analysis).
Factor Unadjusted HR 95% CI p-Value Adjusted HR 95% CI p-Value
Age <70 years 2.1 1.6–2.7 0.001 2.0 1.5–2.7 0.001
70 years Reference Reference
Treatment Surgical 1.3 1.0–1.8 0.04 0.9 0.7–1.3 0.7
Non-surgical Reference Reference
Mechanism of injury Fall from height 1.6 1.0–2.5 0.033 1.1 0.7–1.8 0.7
Transport accident 2.0 1.4–2.8 0.001 1.2 0.8–1.9 0.3
Fall on the same level Reference Reference
HR, hazard ratio, CI, conﬁdence interval, HRs are adjusted for age, sex, type of treatment, and mechanism of injury; if the HR is >1, the patients are more likely to end opioid
intake compared with the reference group.
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explained by differences in patient selection. Whilst some authors
described a frequency of up to 70% of associated fractures,16 our
study excluded all patients with other fractures. We intended to
study the pattern of opioid prescription of a homogeneous cohort
of patients after an isolated acetabular fracture. Some patients may
have been started on opioids due to osteoarthritis, which has been
described as a complication in up to 38% of the cases in one report.4
Moreover, we cannot rule out that some patients may have
received opioid prescriptions during follow-up due to other
diagnoses such as back pain, headache, extremity pain, abdominal
pain, or others. Therefore, we included an age- and sex-matched
cohort to estimate the opioid use in the general population without
the studied fracture type.
We are aware of a considerable use of opioids in the general
elderly population, especially in chronic pain.6 As we wanted to
study a cohort with novel opioid use after fracture, we excluded all
patients that had morphine prescriptions prior to the fracture. We
did not collect data on the reason for opioid use in these excluded
patients.
After adjustment for covariates in the Cox regression-model, we
found only older age to be associated with an increased risk of
prolonged opioid use. It is well documented in the literature, that
elderly patients with acetabular fractures are more likely to have a
poor clinical outcome.16,17,4,19
Long-term opioid therapy has been deﬁned as episodes lasting
longer than 3 months.3,14 Continuous use of opioids may increase
the risk for tolerance development and dose escalations.2 We did
not detect an indication of major dose escalations in 72% of
patients, at least not during the ﬁrst 6 months after fracture. There
were no patients with high morphine doses after two months and
the proportion of patients receiving moderate opioid doses
decreased over time.
The median daily MED was between 17 and 27 mg during
month 1 and 12 after fracture. Dunn et al. studied 9940 patients
who received opioid prescriptions for non-cancer pain. Two thirds
of the patients had a diagnosis of back pain or extremity pain and
the mean daily MED prescribed was 13 mg. The authors concluded
that compared with patients receiving 1–20 mg of opioids per day,
patients with 50–99 mg had a 4 fold increase in overdose risk and
patients with 100 mg or more per day had a 9 fold overdose risk.5
Mahowald et al. presented a mean opioid use of 25 mg in 230
patients with chronic spine pain. The authors concluded that the
treatment was effective and the opioid doses were stable for a
prolonged period of time.15 However, other authors examining
opioid use among patients with back pain found substantial
increases of doses and a limited improvement of pain.8
Our study is limited by the following points. We did not analyse
the prevalence of re-surgery during the study period. Dispensing a
drug is not always equivalent with the actual drug consumption by
the patient. Thus, as a measure of true drug consumption,
prevalence, and incidence ﬁgures presented maybe an over- or
underestimation. Some of the dispensed prescriptions will neverbe used by patients, resulting in an overestimation. In contrast,
additional sources of morphine such as codein (weak opioids)
which is transformed in the liver to morphine, were not included in
this study, resulting in an underestimation. Our study is limited by
the lack of information on clinical pain levels and X-ray ﬁndings of
the fractures. Our ﬁndings do not allow to comment on the
adequacy of the prescribed opioid analgesics. However, our data
illustrate a broad pattern that helps us to understand long-term
prescriptions of opioids in fracture patients. Moreover, we
included a matched control group comparing opioid consumption
in the general population. All databases in this analysis contain
prospectively collected data on a nationwide basis, reducing the
risk of systematic bias. The National Pharmacy Register represents
a source for national medication history and seems to be rather
complete.1 There are no over-the-counter sales of opioid analgesics
in Sweden.
In conclusion, we found a signiﬁcant amount of patients still at
risk for opioid prescriptions several months after acetabular
fracture. However, the median daily dose used was rather low and
patients remaining on opioids displayed a trend towards the use of
lower doses over time. Continuation of opioid use was more likely
in the elderly. To set those ﬁndings into perspective, studies of
patterns of chronic opioid use among patients with other types of
fractures would be valuable.
Acknowledgements
The study was supported by grants from the Karolinska
Institutet, the Stockholm County Council, and the Expert Council
of Analgesic Drugs of the Regional Drug and Therapeutics
Committee (Stockholms La¨kemedelskommitte´).
References
1. Astrand B, Hovstadius B, Antonov K, Petersson G. The Swedish National Phar-
macy Register. Stud Health Technol Inform 2007;129:345–9.
2. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med
2003;349(20):1943–53.
3. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, et al.
Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoe-
pidemiol Drug Saf 2009;18(12):1166–75.
4. Briffa N, Pearce R, Hill AM, Bircher M. Outcomes of acetabular fracture ﬁxation
with ten years’ follow-up. J Bone Joint Surg Br 2011;93(2):229–36.
5. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD,
et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann
Intern Med 2010;152(2):85–92.
6. Eriksen J, Jensen MK, Sjogren P, Ekholm O, Rasmussen NK. Epidemiology of
chronic non-malignant pain in Denmark. Pain 2003;106(3):221–8.
7. Ferguson TA, Patel R, Bhandari M, Matta JM. Fractures of the acetabulum in
patients aged 60 years and older: an epidemiological and radiological study. J
Bone Joint Surg Br 2010;92(2):250–7.
8. Franklin GM, Rahman EA, Turner JA, Daniell WE, Fulton-Kehoe D. Opioid use for
chronic low back pain: a prospective, population-based study among injured
workers in Washington state, 2002–2005. Clin J Pain 2009;25(9):743–51.
9. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic non-
cancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006;
174(11):1589–94.
R.J. Weiss et al. / Injury Extra 43 (2012) 49–53 5310. Gerbershagen HJ, Dagtekin O, Isenberg J, Martens N, Ozgur E, Krep H, et al.
Chronic pain and disability after pelvic and acetabular fractures—assessment
with the Mainz Pain Staging System. J Trauma 2010;69(1):128–36.
11. Giannoudis PV, Grotz MR, Papakostidis C, Dinopoulos H. Operative treatment of
displaced fractures of the acetabulum. A meta-analysis. J Bone Joint Surg Br
2005;87(1):2–9.
12. Giannoudis PV, Pohlemann T, Bircher M. Pelvic and acetabular surgery within
Europe: the need for the co-ordination of treatment concepts. Injury 2007;
38(4):410–5.
13. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and
prevention. Lancet 2006;367(9522):1618–25.
14. Korff MV, Saunders K, Thomas Ray G, Boudreau D, Campbell C, Merrill J, et al. De
facto long-term opioid therapy for noncancer pain. Clin J Pain 2008;24(6):521–7.
15. Mahowald ML, Singh JA, Majeski P. Opioid use by patients in an orthopedics
spine clinic. Arthritis Rheum 2005;52(1):312–21.
16. Matta JM. Fractures of the acetabulum: accuracy of reduction and clinical
results in patients managed operatively within three weeks after the injury.
J Bone Joint Surg Am 1996;78(11):1632–45.
17. Mears DC, Velyvis JH, Chang CP. Displaced acetabular fractures managed
operatively: indicators of outcome. Clin Orthop Relat Res 2003;407:173–86.18. Meyhoff CS, Thomsen CH, Rasmussen LS, Nielsen PR. High incidence of chronic
pain following surgery for pelvic fracture. Clin J Pain 2006;22(2):167–72.
19. Moed BR, WillsonCarr SE, Watson JT. Results of operative treatment of fractures
of the posterior wall of the acetabulum. J Bone Joint Surg Am 2002;84-
A(5):752–8.
20. Murphy D, Kaliszer M, Rice J, McElwain JP. Outcome after acetabular fracture.
Prognostic factors and their inter-relationships. Injury 2003;34(7):512–7.
21. Pohlemann T, Tscherne H, Baumgartel F, Egbers HJ, Euler E, Maurer F, et al.
Pelvic fractures: epidemiology, therapy and long-term outcome. Overview of
the multicenter study of the Pelvis Study Group. Unfallchirurg 1996;99(3):160–
7.
22. Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of
chronic pain: controversies, current status, and future directions. Exp Clin
Psychopharmacol 2008;16(5):405–16.
23. Shaheen PE, Walsh D, Lasheen W, Davis MP, Lagman RL. Opioid equianalgesic
tables: are they all equally dangerous? J Pain Symptom Manage 2009;38(3):409–
17.
24. Sjogren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in
chronic nonmalignant pain patients receiving long-term oral opioid therapy. J
Pain Symptom Manage 2000;19(2):100–8.
